Robert A. Wolff

The University of Texas MD Anderson Cancer Center

Also affiliated with Kleijnen Systematic Reviews (United Kingdom)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Materials and Methods from PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Figshare(2023)10.1158/1078-0432.22446608.v1

Top 100%

0DataRank

Top 100%0 citations

Argun Akçakanat, Huiqin Chen, Kim‐Anh Do, Takafumi Sangai, Farrell Adkins +10 more

Papers

Driven by 48 papers — median percentile 0. Top paper: “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial”.

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1200

N/A

1.5DataRank · unranked

60 citations

Yuki Makino, Jimin Min, Kimal Rajapakshe, Michele Yip-Schneider, C. Max Schmidt +10 more

Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer

Annals of Surgery(2023)10.1097/sla.0000000000005878

N/A

1.5DataRank · unranked

43 citations

Nathan H. Parker, Lianchun Xiao, Keri Schadler, Maria Q. B. Petzel, Laura R. Prakash +18 more

Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-006822

N/A

1.3DataRank · unranked

52 citations

Anne Knisely, David Vining, Scott Kopetz, Michael J. Overman, Milind Javle +16 more

Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00478-3

N/A

0.960DataRank · unranked

34 citations

Jessica M. Frakes, Todd A. Aguilera, Manisha Palta, Brian G. Czito, Manoop S. Bhutani +26 more

Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial

Journal of Clinical Oncology(2024)10.1200/jco.24.00081

N/A

0.619DataRank · unranked

61 citations

Alexander D. Sherry, Bryan M. Fellman, Suyu Liu, Tharakeswara Bathala, Cara Haymaker +25 more

Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older

Pancreatology(2020)10.1016/j.pan.2020.01.005

N/A

0.561DataRank · unranked

41 citations

Jane E. Rogers, Kenneth R. Hess, Robert A. Wolff, Gauri R. Varadhachary, Milind Javle +7 more

Genome-wide association study identifies high-impact susceptibility loci for HCC in North America

Hepatology(2024)10.1097/hep.0000000000000800

N/A

0.557DataRank · unranked

40 citations

Donghui Li, Younghun Han, Jinyoung Byun, Rikita Hatia, Erping Long +48 more

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.986305

N/A

0.489DataRank · unranked

25 citations

Abedul Haque, Deeksha Vishwamitra, Manal M. Hassan, Lianchun Xiao, Bhawana George +11 more

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002

N/A

0.477DataRank · unranked

23 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers

Nature Communications(2020)10.1038/s41467-020-19141-w

N/A

0.477DataRank · unranked

23 citations

Amjad H. Talukder, Ivy Lai, Rebecca K. Davis, Héctor M. Álvarez, Hervé Tiriac +27 more

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162

N/A

0.464DataRank · unranked

21 citations

Jane E. Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind Dasari +11 more

PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer

BMC Cancer(2022)10.1186/s12885-021-09095-7

N/A

0.451DataRank · unranked

9 citations

Suyu Liu, Junsheng Ma, Robert A. Wolff, Shubham Pant, Anirban Maitra +6 more

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget(2022)10.18632/oncotarget.28322

N/A

0.434DataRank · unranked

17 citations

Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao +13 more

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-49915-5

N/A

0.396DataRank · unranked

13 citations

Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman +37 more

Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma

Pancreatology(2020)10.1016/j.pan.2020.11.003

N/A

0.373DataRank · unranked

11 citations

Mohamed Zaid, Matthew H. G. Katz, Laura R. Prakash, Michael P. Kim, Ching‐Wei D. Tzeng +12 more

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy

Cancers(2023)10.3390/cancers15092608

N/A

0.345DataRank · unranked

9 citations

Zongshan Lai, Matthew H. G. Katz, Laura R. Prakash, Hua Wang, Deyali Chatterjee +11 more

Phase I trial of single-photon emission computed tomography–guided liver-directed radiotherapy for patients with low functional liver volume

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae037

N/A

0.340DataRank · unranked

6 citations

Franklin C. Wong, Beth Chasen, William D. Erwin, Prajnan Das, Emma B. Holliday +27 more

Phase I study of hydroxychloroquine plus binimetinib in patients with metastatic pancreatic cancer (the HOPE trial).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps634

N/A

0.269DataRank · unranked

5 citations

J. Jack Lee, Brandon G. Smaglo, Dan Zhao, Michael Sangmin Lee, Robert A. Wolff +5 more

Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer

Journal of Gastrointestinal Oncology(2022)10.21037/jgo-21-471

N/A

0.241DataRank · unranked

4 citations

Bryan K. Kee, Michael J. Overman, Arvind Dasari, Kanwal Raghav, Benny Johnson +6 more

Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of The Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.19.512773

N/A

0.165DataRank · unranked

2 citations

Yuki Makino, Jimin Min, Kimal Rajapakshe, Michele Yip-Schneider, C. Max Schmidt +10 more

Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4122

N/A

0.104DataRank · unranked

1 citations

Aseel Abdalla, Neha Bhagwat, Taylor A. Black, Zhuoyang Wang, Stephanie S. Yee +15 more

The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy

Cancers(2024)10.3390/cancers16193312

N/A

0DataRank · unranked

1 citations

Matthew H. G. Katz, Laura R. Prakash, Dongguang Wei, Yi Tat Tong, Zongshan Lai +11 more

Phase I/II study of TROP2 CAR engineered IL15-transduced cord blood-derived NK cells delivered intraperitoneally for the management of platinum resistant ovarian cancer, mesonephric-like adenocarcinoma, and pancreatic cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps5626

N/A

0DataRank · unranked

9 citations

Hind Rafei, Rafet Başar, Pinaki P. Banerjee, Zeyad Metwalli, Kathryn Lito +13 more

Physical activity and dexamethasone for cancer related fatigue: A preliminary placebo controlled randomized control trial.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.12050

N/A

0DataRank · unranked

0 citations

Vicente Valero, Brandon G. Smaglo, Michael J. Overman, Arvind Dasari, Robert A. Wolff +8 more

Mutational and co-mutational landscape of early onset colorectal cancer

Biomarkers(2025)10.1080/1354750x.2024.2447089

N/A

0DataRank · unranked

24 citations

Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G. White, John Paul Shen +14 more

Incidence of mucositis in patients treated with mTOR inhibitor-based regimens and correlation to treatment response.

Journal of Clinical Oncology(2013)10.1200/jco.2013.31.15_suppl.e13575

N/A

0DataRank · unranked

0 citations

David S. Hong, Siqing Fu, Sarina Anne Piha-Paul, Lacey McQuinn, Gerald Steven Falchook +11 more

Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study

Cancers(2020)10.3390/cancers12123656

N/A

0DataRank · unranked

19 citations

L. Widmann, Annie Dai, Kevin Sun, Jie Zhang, Jun Zhao +13 more

IGF-Child-Turcotte-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16660

N/A

0DataRank · unranked

1 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +9 more

IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.488

N/A

0DataRank · unranked

0 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +8 more

Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

Oncotarget(2021)10.18632/oncotarget.27924

N/A

0DataRank · unranked

3 citations

Sunyoung Lee, Lianchun Xiao, Manal M. Hassan, Aliya Qayyum, Rikita Hiatia +12 more

Phase II trial of bintrafusp alfa in patients with metastatic MSI-H cancers following progression on immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.79

N/A

0DataRank · unranked

15 citations

Michael Lam, Xuemei Wang, Michael J. Overman, Benny Johnson, Bryan K. Kee +7 more

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience

Clinical and Translational Radiation Oncology(2022)10.1016/j.ctro.2021.12.012

N/A

0DataRank · unranked

68 citations

Ethan B. Ludmir, Anirban Maitra, Bruce D. Minsky, Grace L. Smith, Prajnan Das +14 more

3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma

Journal of Clinical Investigation(2022)10.1172/jci151604

N/A

0DataRank · unranked

34 citations

Jenying Deng, Jianhua Ling, Xinqun Li, Yi‐Ju Chiang, Eugene J. Koay +19 more

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

Journal of Hepatocellular Carcinoma(2022)10.2147/jhc.s368208

N/A

0DataRank · unranked

23 citations

Vishal Sahu, Jamie Lombardo, Lianchun Xiao, Bhawana George, Robert A. Wolff +6 more

Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.04.044

N/A

0DataRank · unranked

4 citations

Dalia Elganainy, Mohamed Zaid, Joseph D. Butner, Anshuman Agrawal, Sara Nizzero +15 more

Phase I study of mesenchymal stem cell (MSC)-derived exosomes with KRASG12D siRNA in patients with metastatic pancreatic cancer harboring a KRASG12D mutation.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps633

N/A

0DataRank · unranked

39 citations

Valerie S. LeBleu, J. Jack Lee, Brandon G. Smaglo, Dan Zhao, Michael Sangmin Lee +11 more

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3520

N/A

0DataRank · unranked

9 citations

Eduardo Vilar Sanchez, Ryan Sun, Madhulika Eluri, Van K. Morris, Benny Johnson +11 more

RAS co-mutation and early onset disease represent an aggressive phenotype of atypical (non-V600) BRAF mutant metastatic colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3592

N/A

0DataRank · unranked

0 citations

Dongyun Yang, Hiba I. Dada, Van K. Morris, Xuemei Wang, Arvind Dasari +14 more

Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0340

N/A

0DataRank · unranked

15 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy

The American Journal of Surgical Pathology(2023)10.1097/pas.0000000000002013

N/A

0DataRank · unranked

12 citations

Mehran Taherian, Matthew H. G. Katz, Laura R. Prakash, Deyali Chatterjee, Hua Wang +12 more

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

Cancers(2023)10.3390/cancers15123231

N/A

0DataRank · unranked

4 citations

Matthew H. G. Katz, Laura R. Prakash, Deyali Chatterjee, Hua Wang, Michael P. Kim +9 more

Supplementary Materials and Methods from PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Figshare(2023)10.1158/1078-0432.22446608.v1

Top 100%

0DataRank

Top 100%0 citations

Argun Akçakanat, Huiqin Chen, Kim‐Anh Do, Takafumi Sangai, Farrell Adkins +10 more

Supplementary Materials and Methods from PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

(2023)10.1158/1078-0432.22446608

Top 100%

0DataRank

Top 100%0 citations

Argun Akçakanat, Huiqin Chen, Kim‐Anh Do, Takafumi Sangai, Farrell Adkins +10 more

Data from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

(2023)10.1158/2767-9764.c.6550830.v1

N/A

0DataRank · unranked

0 citations

Michael J. Overman, Michael Hon‐Wah Lam, Christine M. Parseghian, Benny Johnson, Arvind Dasari +17 more

584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0584

N/A

0DataRank · unranked

0 citations

Anne Knisely, Bettzy Stephen, Yali Yang, Juhee Song, Anas Alshawa +9 more

Data from Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

(2023)10.1158/2767-9764.c.6975005.v1

Top 100%

0DataRank

Top 100%0 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

Cancer Biomarkers(2024)10.3233/cbm-230431

N/A

0DataRank · unranked

12 citations

Sunyoung S. Lee, Tarık Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao +17 more

Robert A. Wolff

Indexed papers

Top data-sharing exemplar

Papers